We are actively looking for partners who share our conviction that Andean biodiversity can become world-class biotech. Whether you are a scientist, investor, ingredient buyer, or journalist — let's talk.
We offer unique access to proprietary Andean molecular IP and a first-mover position in the longevity ingredient market.
Co-research agreements for in vitro validation, clinical studies, and molecular characterization. Joint publications in peer-reviewed journals. We bring proprietary Andean botanical material — you bring research infrastructure and scientific credibility.
Licensing agreements for Phytandina-certified extracts. Piceatannol standardized (≥2%), Withaperuvin pool, Betalain concentrate. COSMOS certification pathway in progress. Target partners: Evonik, Givaudan, Seppic, BASF Care Chemicals, and innovative cosmeceutical brands.
Phytandina is at pre-seed stage with a de-risked technology pipeline and a clear B2B commercialization pathway. We seek aligned capital — impact-first biotech funds, family offices with a longevity thesis, and accelerators focused on the Global South and women-led ventures.
Tell us who you are and what you're building. The best collaborations start with an honest conversation.